Position in AGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$698,738
-$255,319 QoQ
Shares Held
228,346
-20.1% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 103 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. AGEN ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in AGEN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $698,738 | 228,346 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $954,057 | 285,646 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,706,734 | 543,546 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $254,870 | 66,200 | Shares | Sole | 2025-11-13 | |
| 2024-09-30 | $923,632 | 168,546 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,260,010 | 254,329 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,141,114 | 5,415,715 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,008,564 | 6,034,415 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $700,986 | 620,342 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,480,024 | 3,425,015 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,789,419 | 4,466,719 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,321,875 | 3,884,115 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,517,344 | 5,130,415 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,585,545 | 3,394,615 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,109,871 | 4,922,715 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,950,680 | 2,779,715 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,445,478 | 1,989,615 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $384,382 | 70,015 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,605,385 | 590,215 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,427,976 | 763,515 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $682,879 | 170,720 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $664,350 | 169,046 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,150,871 | 469,743 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||